Roger Perlmutter leaves Merck after 7 years, joins board at ...

Roger Perlmutter has brought a seven-year stint as head of R&D at Merck & Co/MSD to a close, jumping ship to take on an advisory role at machine-learning specialist Insitro.

Indivior ex-CEO could face jail time after opioid conviction

The resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – and possible prison sentence – after he pleaded guilty in a US feder

David Loew swaps Sanofi’s top vaccine job for CEO role at Ip...

Sanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as the new chief executive of French specialty drugmaker Ipsen, taking over

NICE names Gillian Leng as CEO, replacing Andrew Dillon

MPs back Nebhrajani as NICE’s new chair after vetting meetin...

NICE chair nominee Nebhrajani to face MP scrutiny next week